CGCheryl E. Gariepy

Cheryl E. Gariepy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cheryl E. Gariepy has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pancreatic Enzyme Use Reduces Pancreatitis Frequency in Children With Acute Recurrent or Chronic Pancreatitis: A Report From INSPPIRE

    by Alvin Jay Freeman, Kenneth Ng, Fuchenchu Wang, Maisam A. Abu-El-Haija, Ankur Chugh, Gretchen A. Cress, Douglas S. Fishman, Cheryl E. Gariepy, Matthew J. Giefer, Praveen Goday, et al.

    INTRODUCTION: Among children who suffer from acute recurrent pancreatitis (ARP) or chronic pancreatitis (CP), acute pancreatitis (AP) episodes are painful, often require hospitalization, and contribute to disease complications and progression. Despite this recognition, there are currently no interventions to prevent AP episodes. In this retrospective cohort study, we assessed the impact of pancreatic enzyme therapy (PERT) use on clinical outcomes among children with pancreatic-sufficient ARP or CP. METHODS: Children with pancreatic-sufficient ARP or CP in the INSPPIRE-2 cohort were included. Clinical outcomes were compared for those receiving vs not receiving PERT, as well as frequency of AP before and after PERT. Logistic regression was used to study the association between development of AP episodes after starting PERT and response predictors. RESULTS: Among 356 pancreatic-sufficient participants, 270 (76%) had ARP, and 60 (17%) received PERT. Among those on PERT, 42% did not have a subsequent AP episode, during a mean 2.1 years of follow-up. Children with a SPINK1 mutation (P = 0.005) and those with ARP (compared with CP, P = 0.008) were less likely to have an AP episode after starting PERT. After initiation of PERT, the mean AP annual incidence rate decreased from 3.14 down to 0.71 (P < 0.001). DISCUSSION: In a retrospective analysis, use of PERT was associated with a reduction in the incidence rate of AP among children with pancreatic-sufficient ARP or CP. These results support the need for a clinical trial to evaluate the efficacy of PERT to improve clinical outcomes among children with ARP or CP.


  • Insights Through Detailed Immunophenotyping into The Immune Etiology Of Indeterminate Pediatric Acute Liver Failure (IND-PALF): An Immune Dysregulatory Disease

    by Amrita Basu, Amanda Campbell, Carol Potter, Amanda Jacobson-Kelley, Cheryl Gariepy, Rajinder Bajwa, Sonja Chen, Heather Costello, Peter Mustillo, Roshini Abraham

  • Pediatric-to-Adult Transfer of Care in Patients With Pancreas Disease: Recommendations for Care and Research Opportunities

    by Cheryl E. Gariepy, Luis F. Lara, Jeffrey J. Easler, Ala Shaikhkhalil, Aliye Uc

    Young adults who have experienced recurrent acute pancreatitis and chronic pancreatitis as children or adolescents are vulnerable to poor follow-up and disease management during the transfer from the pediatric to adult healthcare system. Although formalized transition programs for young adults have been developed and described for other disease conditions, no such program has been described for young adults with pancreatic disease. This document is the first expert opinion outlining the important aspects of a transitional care and transfer program tailored to youth with recurrent acute and chronic pancreatitis. We emphasize the unique needs of these patients as they transfer to adult health care and the need for further research. The goal of improved transitional care and transfer is to enhance the services provided to adolescents/young adults with pancreatic disease in both healthcare settings and improve continuity of follow-up care.


  • Interobserver Agreement for CT and MRI Findings of Chronic Pancreatitis in Children: A Multicenter Ancillary Study Under the INSPPIRE Consortium

    by Andrew T. Trout, Maisam Abu-El-Haija, Sudha A. Anupindi, Megan B. Marine, Michael Murati, Andrew S. Phelps, Mitchell A. Rees, Judy H. Squires, Kate M. Ellery, Cheryl E. Gariepy, et al.

    Background: Imaging findings represent key criteria for diagnosing chronic pancreatitis in children. Understanding radiologists' agreement for imaging findings is critical to standardizing and opti...


  • Demographics and risk factors for pediatric recurrent acute pancreatitis

    by Cheryl E. Gariepy, Chee Y. Ooi, Asim Maqbool, Kate M. Ellery

    Purpose of review: Approximately 20–30% of children who experience one episode of acute pancreatitis will have at least one additional episode. For some children, pancreatitis recurs multiple times and in a few years is followed by the diagnosis of chronic pancreatitis. Identifying risk factors for recurrent episodes and disease progression is critical to developing therapeutic interventions. Recent findings: Obesity is driving an increase in biliary stone disease and severe acute pancreatitis. Recurrent acute pancreatitis (RAP) may lead to the development of diabetes through autoimmune mechanisms. Cystic fibrosis or CFTR-related disorders may present as RAP and CFTR modulator therapy can increase or decrease the risk of acute pancreatitis in these populations. Children with Crohn disease have a three-fold risk of acute pancreatitis over the general population while children with ulcerative colitis are at increased risk for pediatric autoimmune pancreatitis, a disorder that may be distinct from autoimmune pancreatitis described in adults. Obstructive jaundice in the absence of identified mechanical factors may be a presenting sign of pediatric autoimmune pancreatitis. Summary: Pediatric RAP is a painful condition that leads to gland destruction and functional insufficiency. Risk factors are being clarified but preventive treatments remain elusive.


  • Open Access

    Diabetes Mellitus in Children with Acute Recurrent and Chronic Pancreatitis

    by Melena D. Bellin, Mark Lowe, M. Bridget Zimmerman, Michael Wilschanski, Steven Werlin, David M. Troendle, Uzma Shah, Sarah J. Schwarzenberg, John F. Pohl, Emily Perito, et al.

    Objectives: Adults with chronic pancreatitis (CP) have a high risk for developing pancreatogenic diabetes mellitus (DM), but little is known regarding potential risk factors for DM in children with acute recurrent pancreatitis (ARP) or CP. We compared demographic and clinical features of children with ARP or CP, with and without DM, in the INternational Study Group of Pediatric Pancreatitis: In Search for a CuRE (INSPPIRE) registry.Methods: We reviewed the INSPPIRE database for the presence or absence of physician‐diagnosed DM in 397 children, excluding those with total pancreatectomy with islet autotransplantation, enrolled from August 2012 to August 2017. Patient demographics, BMI percentile, age at disease onset, disease risk factors, disease burden, and treatments were compared between children with DM (n = 24) and without DM (n = 373).Results: Twenty‐four children (6% of the cohort) had a diagnosis of DM. Five of 13 tested were positive for beta cell autoantibodies. The DM group was 4.2 years [95% confidence interval (CI) 3–5.4] older at first episode of acute pancreatitis, and tended to more often have hypertriglyceridemia [odds ratio (OR) 5.21 (1.33–17.05)], coexisting autoimmune disease [OR 3.94 (0.88–13.65)] or pancreatic atrophy [OR 3.64 (1.13, 11.59)].Conclusion: Pancreatic atrophy may be more common among children with DM, suggesting more advanced exocrine disease. However, data in this exploratory cohort also suggest increased autoimmunity and hypertriglyceridemia in children with DM, suggesting that risk factors for type 1 and type 2 DM, respectively may play a role in mediating DM development in children with pancreatitis.


  • Causal Evaluation of Acute Recurrent and Chronic Pancreatitis in Children

    by Cheryl E. Gariepy, Melvin B. Heyman, Mark E. Lowe, John F. Pohl, Steven L. Werlin, Michael Wilschanski, Bradley Barth, Douglas S. Fishman, Steven D. Freedman, Matthew J. Giefer, et al.

    Objectives: Acute recurrent pancreatitis (ARP) and chronic pancreatitis (CP) have been diagnosed in children at increasing rates during the past decade. As pediatric ARP and CP are still relatively rare conditions, little quality evidence is available on which to base the diagnosis and determination of etiology. The aim of the study was to review the current state of the literature regarding the etiology of these disorders and to developed a consensus among a panel of clinically active specialists caring for children with these disorders to help guide the diagnostic evaluation and identify areas most in need of future research.Methods: A systematic review of the literature was performed and scored for quality, followed by consensus statements developed and scored by each individual in the group for level of agreement and strength of the supporting data using a modified Delphi method. Scores were analyzed for the level of consensus achieved by the group.Results: The panel reached consensus on 27 statements covering the definitions of pediatric ARP and CP, evaluation for potential etiologies of these disorders, and long‐term monitoring. Statements for which the group reached consensus to make no recommendation or could not reach consensus are discussed.Conclusions: This consensus helps define the minimal diagnostic evaluation and monitoring of children with ARP and CP. Even in areas in which we reached consensus, the quality of the evidence is weak, highlighting the need for further research. Improved understanding of the underlying cause will facilitate treatment development and targeting.


  • Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

    by Sylvia Y. Ofei, Cheryl Gariepy, James Hanje, Tracey Sisk, Curt J. Daniels, Ali N. Zaidi